Newsfeeds - Spark Newswire

1 minute read

Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation

Today, 4:23 PM

Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF) has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the application of psychedelics molecules and therapies in smoking cessation.

MYCOF

6 minute read

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies

By Natan Ponieman

Today, 4:23 PM

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In just a couple of years, psychedelics took the world of investing by storm.

AGNPF

5 minute read

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies

By Natan Ponieman

Today, 4:23 PM

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symbol “GHRS.”

BRAXF

6 minute read

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More

By Natan Ponieman

Today, 4:23 PM

Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group initiated coverage of companies in the psychedelics space, giving a bullish Buy rating to all 10.

CLXPF

4 minute read

Mydecine Identifies 4 Psychedelic-Related Drugs to Tackle the Mental Health Crisis

By Shashank Jacob

Today, 4:23 PM

Photo by Christopher Ott on Unsplash

MYCOF

1 minute read

Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program

By Natan Ponieman

Today, 4:23 PM

Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF), a biotech company in the psychedelics space, announced on Wednesday the launch of a virtual drug discovery program that will use artificial intelligence and machine learning to inform its drug discovery process.

MYCOF

4 minute read

Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility

By Natan Ponieman

Today, 4:23 PM

The Nasdaq welcomed its third psychedelics company this week, with the acquisition of MagicMed Industries by Enveric Biosciences (NASDAQ:

CSE:DELC

2 minute read

Uncategorized

Mydecine Posts $26.9M Net Loss For 2020: What’s Ahead For Psychedelic Stock

By Natan Ponieman

Today, 4:23 PM

Denver-based Mydecine Innovations Group (NEO: MYCO) (Pink: MYCOF) released its 2020 yearly financial results this week, ending the year with $2.2 million in cash. The company reported having raised over $30 million more since the beginning of 2021.

MYCOF